Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives

BACKGROUND: Human parvovirus B19 (B19V) is a frequent contaminant of blood and plasma-derived medicinal products. To ensure the quality and safety of plasma-derived products, European regulations, Plasma Protein Therapeutics Association (PPTA) standard and FDA guidelines require testing of manufactu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Junting, Ma, Yuyuan, Zhao, Xiong, Guo, Yi, Huangfu, Chaoji, Fang, Chi, Fan, Rui, Lv, Maomin, Yin, Huiqiong, Zhang, Jingang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596515/
https://www.ncbi.nlm.nih.gov/pubmed/26445095
http://dx.doi.org/10.1186/s12985-015-0396-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596515/
https://www.ncbi.nlm.nih.gov/pubmed/26445095
http://dx.doi.org/10.1186/s12985-015-0396-z

Ejemplares similares